Another Bayer G4A-supported platform is Carenostics, which uses AI tools to help identify undiagnosed chronic kidney disease. AI also supports Carenostics to create more accurate predictions of how the disease progresses throughout the population, including potential hospitalisation figures and complications, enabling better healthcare resource planning. Tools like this have great potential to tackle inequality in healthcare by closing gaps in care for underserved patients.
Bridging the gaps in health inequality, AI has huge potential in streamlining medical check-ups and disease screenings, making healthcare more affordable for all. A recent research programme at the Chinese University of Hong Kong developed an AI-based faecal detection system that can help to identify colorectal cancers and some cardiovascular diseases. The new system is significantly cheaper than traditional screening methods like MRI or CT scans, breaking down some of the typical financial barriers to early screening and precision diagnosis.